These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 32016960)
21. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis. Liu C; Jiang F; Zhang X; Xu X Cancer Manag Res; 2020; 12():2777-2788. PubMed ID: 32425595 [TBL] [Abstract][Full Text] [Related]
22. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of lncRNA UCA1 facilitates apoptosis and reduces proliferation in multiple myeloma via regulation of the miR-1271-5p/HGF axis. Yang Y; Chen L J Chin Med Assoc; 2019 Sep; 82(9):699-709. PubMed ID: 31356563 [TBL] [Abstract][Full Text] [Related]
24. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis. Guo C; Wang H; Jiang H; Qiao L; Wang X Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503 [No Abstract] [Full Text] [Related]
25. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis. Xu H; Wang L; Jiang X Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430 [TBL] [Abstract][Full Text] [Related]
26. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8. Li J; Zhu T; Weng Y; Cheng F; Sun Q; Yang K; Su Z; Ma H Thorac Cancer; 2022 May; 13(9):1381-1390. PubMed ID: 35396925 [TBL] [Abstract][Full Text] [Related]
27. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1. Liang C; Yang Y; Guan J; Lv T; Qu S; Fu Q; Zhao H Pathol Res Pract; 2018 Sep; 214(9):1474-1481. PubMed ID: 30107990 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2). Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538 [TBL] [Abstract][Full Text] [Related]
29. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer. Wu X; Qiu L; Feng H; Zhang H; Yu H; Du Y; Wu H; Zhu S; Ruan Y; Jiang H Life Sci; 2022 Mar; 293():120328. PubMed ID: 35051418 [TBL] [Abstract][Full Text] [Related]
30. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo. Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA UCA1 mediates proliferation and metastasis of laryngeal squamous cell carcinoma cells via regulating miR-185-5p/HOXA13 axis. Sun YD; Liu Q; Yang HX; Tian L; Wang J; Zeng L; Zhou XW Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1366-1378. PubMed ID: 33629307 [TBL] [Abstract][Full Text] [Related]
32. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Liu YY; Zhang LY; Du WZ Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis. Qi X; Chen D; Yu W; Wang L; Liu L; Tao X Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984 [TBL] [Abstract][Full Text] [Related]
34. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels. Wambecke A; Ahmad M; Morice PM; Lambert B; Weiswald LB; Vernon M; Vigneron N; Abeilard E; Brotin E; Figeac M; Gauduchon P; Poulain L; Denoyelle C; Meryet-Figuiere M Mol Oncol; 2021 Dec; 15(12):3659-3678. PubMed ID: 34160887 [TBL] [Abstract][Full Text] [Related]
35. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR. Wang L; Yu M; Zhao S J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607 [TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936 [TBL] [Abstract][Full Text] [Related]
37. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p. Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259 [TBL] [Abstract][Full Text] [Related]
38. CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis. Ying H; Zhao R; Yu Q; Zhang K; Deng Q Drug Dev Res; 2022 Apr; 83(2):512-524. PubMed ID: 34541682 [TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265 [TBL] [Abstract][Full Text] [Related]
40. LncRNA TUG1 facilitates proliferation, invasion and stemness of ovarian cancer cell via miR-186-5p/ZEB1 axis. Zhan FL; Chen CF; Yao MZ Cell Biochem Funct; 2020 Dec; 38(8):1069-1078. PubMed ID: 32390141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]